Trials involving 1,077 healthy adults between April 23 and May 21 showed the injection led to them making antibodies and white blood cells that can fight COVID-19. It did not produce any serious side effects.
Professor Sarah Gilbert, from the University of Oxford, UK, said: “There is still much work to be done before we can confirm if our vaccine will help manage the COVID-19 pandemic, but these early results hold promise. “As well as continuing to test our vaccine in phase-three trials, we need to learn more about the virus — for example, we still do not know how strong an immune response we need to provoke to effectively protect against Sars-Cov-2 infection.
“If our vaccine is effective, it is a promising option as these types of vaccine can be manufactured at large scale. “A successful vaccine against Sars-Cov-2 could be used to prevent infection, disease and death in the whole population, with high-risk populations such as hospital workers and older adults prioritized to receive vaccination.”
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: MSNBC - 🏆 469. / 51 Read more »